A discussion of how genetic variations can be used to predict an individual’s response to certain pharmacological drugs. The presentation focuses on explaining the link between genetics and drug metabolism, analyzing DTC and clinical pharmacogenomic testing resources, and discussing cases in which pharmacogenomic testing can have an impact on drug therapy.

This event is part of the DNA Interest Group.

Recorded on May 22, 2018 at the Iowa City Public Library.